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Abstract 
Proteasomes catalyze the non-lysosomal, An-dependent selective breakdown of ubiquitinated proteins and are thought to be responsible for MHC 
class I-restricted antigen presentation. Recently, we reported that gamma interferon (IFN-y) induced not only marked synthesis of the MHC-encoded 
proteasome subunits LMP2 and LMP7, but also ahnost complete loss of two unidentified proteasome subunits tentatively designated as X and Y 
in various human cells. Here, we show that subunit X is a new proteasomai subunit highly homologous to LMW, and that subunit Y is identical 
to the LM~-related proteasomal subunit delta. Thus, IFN-y appears to induce subunit replacements of X and Y by LMP7 and LMPZ, respectively, 
producing ‘Juno-prot~omes’ with the functional diversity responsible for processing of endogenous antigens. 
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1. Introduction 
Recent progress in studies on the mechanism of the 
MHC class I-restricted antigen presentation pathway 
have indicated that intracellular antigenic peptides gen- 
erated by the ubiq~tin pathway are transported into the 
endoplasmic reticulum through the TAP112 heterod- 
imeric peptide transporter [ 121. Cytosolic proteasomes 
functioning as an extra-lysosomal, ATP-dependent pro- 
tease to selectively degrade ubiquitinated proteins [3,4] 
are therefore proposed to be involved in the processing 
of intracellular antigens. Two novel proteasomal genes 
LMP2 and LMP7 were found to be localized within the 
MHC class II region, closely linked to the TAP1 and 
TAP2 genes [5]. Moreover, expression of these four poly- 
morphic genes was found to be markedly up-regulated 
by gamma-inte~eron (IFN-y), a major i~unomod~a- 
tory cytokine [5,6], which is secreted by activated T-cells 
and NK cells in response to non-self antigens. 
Recently, IFN-y was found to change the specificity 
of proteasomes for peptide degradation, increasing their 
activities for endoproteolytic cleavage of peptide bonds 
on the carboxyl side of basic and neutral amino acid 
residues of proteins, but depressing their activity for pep- 
tides containing acidic amino acid residues [6-g]. This 
altered specificity is apparently consistent with the prop- 
erties of antigenic peptides associated with cell surface 
class I molecules [9]. However, it is unknown how the 
specificity of proteasomes is changed, althougb an im- 
portant role for the LMP2 and LMP7 subunits in the 
complex has been suggested [5]. We recently found that 
IFN-y resulted in not only a high induction of LMP2 
and LMP7 synthesis, but also a marked reduction in the 
synthesis of two newly-identified subunits of pro- 
teasomes, tentatively named X and Y [6]. In the present 
work, we report that these X and Y subunits are a novel 
class of proteasomal subunits with high homology to 
LMP7 and LMP2, respectively, and that subunit Y is 
identical to proteasomal subunit delta, as reported previ- 
ously [lo]. These findings suggest that the specificity of 
proteasomes is changed by an IFN-~-indu~ change of 
subunits from X/Y to LMP712, and that this change may 
be responsible for accelerated processing of non-self en- 
dogenous antigens. 
2. Materials and methods 
*Corresponding author. The 20s proteasome from human kidney was purified to near homo- 
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geneity by conventional chromatographic techniques, as described be- 
fore [ll]. Peptide antibodies were raised in rabbits by immunization 
with peptides corresponding to the C-terminals of LMP2 (HRVIL- 
GNELPKFYDE) and LMP7 (TDVSDLLHQYREANQ) as described 
[6]. A monoclonal antibody against the delta subunit of human pro- 
teasomes was produced in hybridoma cells ([12]; Hendil et al., in prep- 
aration). Immunoelectrophoretic blot analysis was carried out by the 
method of Towbin et al: [13]. Samples (50 pug protein) separated by 
two-dimensional electrouhoresis bv the method of G’Farrell (2D- 
PAGE) [14] were transferred electrophoretically to Immobilon-PVDF 
membranes (Millipore). The membranes were pretreated with Block 
Ace (Yukijirushi Co., Sapporo), and immunoreactive protein detected 
with antibodies and an ECL system (Amersham). 
For the isolation of X and Y, samples (150 ,ug protein) of pro- 
teasomes were subjected to ZD-PAGE, transferred to membranes, and 
detected by staining with Coomassie brilliant blue. The spots corre- 
sponding to X and Y from approximately 35 membranes were excised 
and digested with lysyl-endopeptidase ortrypsin. The digest was sepa- 
rated bv reverse-nhase HPLC on a uBONSADPHERW Cl8lOOA 
column-(2.1 x IS&mm) developed with a linear gradient of acetonitrile 
containing 0.1% trilluoroacetic acid. The eluate was monitored by 
measuring the absorbance at 215 nm. The peak fractions collected were 
used for N-terminal amino acid sequencing. Peptides were subjected to 
automated Edman degradation in a Model 477A gas-phase sequencer 
(Applied Biosystems, Inc.), and phenylthiohydantoin derivatives were 
identified with a Model Applied Biosystems 120A phenylthiohydantoin 
amino acid analyzer on-line system. 
3. Results 
3.1. IdentiJication ofproteasome subunits X and Y down- 
regulated in response to IFN--y 
The exact subunit composition of the human 20s pro- 
teasome was examined by 2D-PAGE. The purified en- 
zyme from human kidney was separated into multiple 
components with molecular masses (M,) of 21 kDa to 33 
High PI (-10) 
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kDa with a range of isoelectric points from 4 to 10 
(Fig.lA). The protein profile was very similar to that of 
the fluorogram obtained for the immunoprecipitate with 
anti-proteasomal antibody from cell extracts metaboli- 
cally labelled with [35S]methionine r ported recently [6]. 
The protein spots corresponding to LMP2 and LMP7 
(shown by arrows) were detected by immunoblot analy- 
sis with specific antibodies against LMP2 and LMP7, 
which had been raised in rabbits by immunization with 
peptides ynthesized on the basis of the C-termini of their 
primary structures reported before [6]. LMP2 and LMP7 
were identified as newly-synthesized subunits that were 
markedly induced by treatment with IFN-)I [6]. On the 
other hand, the two spots designated as X and Y (indi- 
cated by circles) were found to be the two subunits down- 
regulated in response to IFN-y detected in the fluoro- 
gram mentioned above, based on their Mrs and pIs and 
the positions of other proteasomal subunits [6]. To ob- 
tain information on the structures of these proteasomal 
subunits X and Y, we analyzed them by protein-chemical 
and immunological techniques. 
3.2. Subunit Y is identical to proteasomal subunit delta 
with a high homology to LMP2 
For determining the primary structure of protein Y, 
after transfer from 2D-PAGE to PVDF membranes, its 
spot was excised and digested with lysyl-endopeptidase. 
The digest was separated by reverse-phase HPLC and 
the peak fractions were used for N-terminal amino acid 
sequencing. One fragment of Y was determined to have 
the sequence FAVATLPPA, which was completely in 
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Fig. 1. Electrophoretic analysis of human kidney ,proteasomes and immunological identification of Y as subunit delta. (A) Subunit pattern of human 
kidney proteasomes separated by ZD-PAGE and stained with Coomassie brilliant blue. The two spots shown by arrowheads were identified as LMP2 
and LMP7 by immunoblot analysis with their respective antibodies [6]. The two spots shown by circles were markedly down-regulated by IFN-y 
treatment in various cell lines, and were tentatively named X and Y [6]. (B) Immunoblot analysis using anti-delta monoclonal antibody MCP421. 
The positions of Y and LMP2 are shown by an arrow and stippled circle, respectively. Note that anti-delta reacted specifically with the spot of Y, 
but not with that of LMP2. 
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LMP7 1 
LMP7 61 GERNVQIEMAH~QHGVIAAVDSRASAGSYISALRVNKVIEINPYLLGTMSGC 
X (a) m 
LMP7 121 AADCQYWERLLAKECRLYYLRNa,_LSNMMCQYRGMGLSMGSMICGWDKKG 
X (b) w 
LMP7 181 
X 
PGLYY~EHGTRLSGNMFSTGSGNTYAYG~DS~~P~IAYATH~S 
(of q SYDb_ fd)b 
KEDGWVKVESTDVSDLLHQYREANQ 
WR 
MALLDVCGAPRGQRPESALPVAGSGRRSDPGHYSFSMRSPELALPRGMQPTEFFQSLGGD 
Fig. 2. Partial structural analysis of subunit X from human liver proteasomes. Sequence alignment of peptides derived from subunit X with those 
of human LMP7. Identical amino acid residues are boxed by black. Subunit X was digested with lysyl-endopeptidase (peptides a and b) or trypsin 
(peptides c and d) and the fragments eparated by reverse-phase HPLC. 
accord with the C-terminal sequence of the proteasomal 
subunit delta, as judged by a compu~r-assisted homol- 
ogy research. Subunit delta has been reported by De- 
Martin0 et al. [lo] to be a unique proteasomal subunit, 
showing high similarity with LMP2, although its cDNA 
clone did not encode the full-length translational region. 
Moreover, we found that anti-delta monoclonal anti- 
body reacted specifically with the spot Y on im- 
munoblotting analysis after separation by 2D-PAGE. 
This anti-delta antibody did not react with LMP2 
(Fig.lB), despite the high sequence similarity of these 
two porteins (over 60% similarity). Thus we conclude 
that subunit Y is identical to delta and possibly related 
in function to LMP2 
3.3. Subunit X is a new proteasomal subunit highly 
homologous to LMP7 
To obtain the structural information on the protein 
named X, we generated several peptides by digestion 
with lysyl-endopeptidase or trypsin from the spots trans- 
ferred to PVDF membranes after 2D-PAGE and isolated 
the resulting peptides by reversed-phase HPLC (data not 
shown). By N-terminal amino acid sequencing, the 
amino acid sequences of four fra~ents were determined 
to be as shown in Fig. 2A. Sequence alignment of the 
peptides with the primary structure of human LMP7 
indicated that the peptides derived from protein spot X 
were very similar to those of LMP7 (Fig. 2). However, 
X was not identical to LMP7 itself, because anti-LMP7 
antibody reacted specifically with subunit LMP7 of the 
proteasomal subunits, but did not react with X (data not 
shown). Moreover, the sequence TTXLAFK is almost 
identical to that of a peptide fragment named pro- 
teasomal subunit Epsilon ~ILAF~RXG~V~- 
SRATAGGYF) reported by Lee et al. [15]. The Epsilon 
sequence is highly similar, but not identical, to that of 
LMP7. Thus, we conclude that the X is a novel pro- 
teasomal subunit that is closely related with LMP7. 
4. Discussion 
In the present study, we demonstrated that pro- 
teasomal subunits X and Y, which are down-regulated 
in response to IFN-y reagent, have extremely high 
similarity with class II MHC~n~~ed subunits LMP7 
and LMP2, respectively, which are up-regulated by 
IFN-7. These findings strongly suggest that IFN-y in- 
duces substitutions of LMP7 and LMP2 for X and Y, 
forming proteasomes with a different subunit organiza- 
tion. Recently, we [6] and others [7,8] reported that INF- 
y affects the proteolytic functions of proteasomes, 
greatly enhancing their chymotrypsin-like and trypsin- 
like peptidase activities and decreasing their peptidylglu- 
tamyl-peptide hydrolyzing activity. These changes of 
peptidase activities apparently correspond to the proper- 
ties of peptides associated with cell surface class I mole- 
cules, because the carboxyl sides of these antigenic pep- 
tides consist mainly of hydrophobic and basic amino 
acid residues, not acidic amino acid residues (for review, 
see 191). Thus alteration in the structural organization of 
proteasomes by IFN-I/ modifies their functions, presum- 
ably to accelerate the processing of non-self antigens. 
These findings suggest that intracellular antigens can be 
processed by IFN-y-modified proteasomes and that the 
peptides generated are transported into the endoplasmic 
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ret&l= through the two putative transporters to be 
assembled with MHC class I molecules for presentation 
on the cell surface. Thus, IFN-y-induced structural (and 
possibly functional) heterogeneity of subunit assembly of 
proteasomes may be responsible for immuno-regula- 
tions, such as antigen processing/presentation. Based on 
these findings, we propose the name ‘immuno-pro- 
teasomes’, for proteasomes containing LMP2 and LMP7 
subunits, with functional diversity acquired through al- 
teration of their subunit assembly in response to IFN-y. 
Previously, we reported that IFN-7 greatly increased 
the levels of the mRNAs encoding LMP2 and LMP7 
without affecting those of any other subunits examined 
in various types of human cells, in which enhanced levels 
of these two mRNAs were roughly correlated with those 
detected by immunoblot analysis with their antibodies. 
This finding suggests that the IFN-)/ induced pro- 
teasomes are formed by de novo synthesis, possibly due 
to change of transcription. Moreover, we found in pulse- 
chase experiments that the IFN-y-dependent change of 
the subunit pattern resulted in alterations in the assembly 
of newly synthesized subunits, but not the reorgani~tion 
or modification of pre-existing proteasomes, because 
IFN-y did not affect the subunit pattern of pre-existing 
proteasomes [6]. Interestingly, however, the mRNA level 
of subunit delta (i.e. Y) was not affected by treatment 
with IFN-r [6], suggesting that complete loss or a 
marked decrease in the expression of subunit Y and 
probably also X is due to regulation at the post-transla- 
tional level. This alteration might be due to repression 
of their biosyntheses at the translational evel. Alterna- 
tively, LMP2 and LMP7 may be assembled into the pro- 
teasomal complex preferentially to Y and probably also 
X, and the X and Y subunits not assembled into the 
complex may be degraded rapidly. The exact mechanism 
of subunit substitution is unknown, but it is of interest 
that the synthesis of X and Y is regulated at a post- 
translational level in response to IFN-)I, in marked con- 
trast to the transcriptional regulations of the LMP2 and 
LMP7 genes. By using these novel mechanisms of action, 
IFN-I)I induces the replacement of X/Y by LMP2/7, sug- 
gesting that proteasomes with different subunit composi- 
tion are generated in cells in response to extracellular 
signals such as IFN-y. 
Molec~ar genetic studies on yeast have shown that 
most proteasome genes are essential for cell proliferation 
[3]. Interestingly, chromosomal deletion of the PRE2 
gene, which is thought to be a homologue of LMP7 in 
budding yeast, is lethal [16]. In contrast, however, human 
cells lacking the LMP7 gene grow normally, indicating 
that this gene is dispensable [5]. This finding initially 
suggested that this subunit has different roles in different 
organisms. However, here we found that mammalian 
cells have two homologous genes encoding X with 
LMP7, and thus the actual homologue of PRE2 may be 
X, not LMP7, although it is unknown whether X is an 
essential gene. The evolution of the PRE2 gene seems 
interesting considering that it is essential in yeast and 
seems to be related to acquiring immunity in mammals. 
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